You just read:

Foamix Announces Integrated Efficacy Results from the FMX103 1.5% Topical Minocycline Foam Phase 3 Program for Rosacea

News provided by

Foamix Pharmaceuticals Ltd.

18 Feb, 2020, 23:07 IST